IMBiologics Corp. (KOSDAQ:493280)

South Korea flag South Korea · Delayed Price · Currency is KRW
104,000
+78,000 (300.00%)
At close: Mar 20, 2026
Market Cap1.54T
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out14.79M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,095,726
Average Volume365,242
Open104,000
Previous Close26,000
Day's Range101,500 - 104,000
52-Week Range26,000 - 104,000
Betan/a
RSIn/a
Earnings Daten/a

About IMBiologics

IMBiologics Corp., a biotechnology company, engages in developing immunomodulatory antibody therapeutics to treat autoimmune diseases and cancer. The company uses Optimal Antibody Modality Manufacturing Technology (IM-OpDECon) for developing differentiated treatments for autoimmune diseases and immuno-oncology based on immuno-modulatory biologics. Its products include IMB-101, a bispecific therapeutic antibody that targets OX40L and TNF to modulate pathological immune mechanisms mediating Th1/Th17 immune responses; IMB-102; IMB-201, an antibody... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 493280
Full Company Profile